top of page

Writer v. Big Pharma: How John Green, Author and YouTuber, Fought the Evergreening of a Drug Patent

By: Rachel Bier

Tuberculosis (TB), an illness caused by the bacterium Mycobacterium tuberculosis,[1] is the deadliest disease in human history.[2] In the 1950s and 1960s, scientists developed several drugs that could treat TB.[3] These developments meant that TB became a curable disease.[4] However, TB remains a terrible epidemic in poor communities around the world.[5] About 4,000 people die from TB every day,[6] with over eighty percent of those deaths occurring in low- and middle-income countries.[7]

To tackle this enormous global health crisis, on September 26, 2018, the United Nations (U.N.) held the first high-level meeting on ending TB.[8] At that meeting, the participants drafted a resolution that set forth commitments for Member States to follow to reach the goal of ending the tuberculosis pandemic[9] by 2030, which was then adopted by the General Assembly.[10] Since the first meeting, some progress has been made in combating TB.[11] However, the global Covid-19 pandemic has slowed progress and further strained healthcare systems around the world.[12]

In order to set updated and more effective goals to fight TB, the U.N. General Assembly held a second high-level meeting on September 22, 2023.[13] The subject of the meeting was to end the plague of tuberculosis, “in particular, by ensuring equitable access to prevention, testing, treatment and care.”[14] In attendance at the meeting were world leaders, TB survivors, and representatives of civil society organizations. One of the civil society representatives was John Green,[15] a famous YouTuber, YA novelist,[16] and TB activist.[17]

Green, working in partnership with other TB activists like the global health and social justice organization Partners in Health (PIH),[18] and his community of online followers known as Nerdfighteria,[19] has played an important part in the fight to end TB. Most notably, Green’s activism has directly made the critical medication Sirturo, known generically as bedaquiline,[20] more accessible to patients in developing countries.[21]

Bedaquiline is a medication that targets forms of TB that are otherwise drug-resistant, making it a highly important tool in combating the TB epidemic.[22] Bedaquiline was developed and patented by the pharmaceutical giant Johnson & Johnson (J&J) in 2012.[23] The majority of the funding for bedaquiline’s research and development came from public funding, but J&J held a monopoly on the drug.[24] J&J’s patent was set to expire in 2023, which would allow the manufacture of cheaper generic versions and could save the lives of millions of low-income patients. [25] In an attempt to “evergreen” its control over the supply of bedaquiline, J&J slightly modified the drug’s composition in order to be able to enforce a secondary patent.[26] Imposing this secondary patent would mean generic bedaquiline would remain out of reach of scores of TB patients for several more years.[27] Hundreds of thousands of people who could have otherwise been cured would die of TB.[28]

Determined to stop this from happening, on July 11, 2023, John Green posted a video on his YouTube channel Vlogbrothers entitled, Barely Contained Rage: An Open Letter to Johnson & Johnson.[29] In the video, he described the great injustice that would occur if J&J enforced its patent and allowed thousands of people to die from lack of access to generic bedaquiline.[30] He called on J&J to remain true to its corporate credo: “We believe our first responsibility is to the patients.”[31] Green then called on his followers to pressure J&J not to enforce its secondary patent.[32] In response, J&J put out a statement denying that it was acting in bad faith.[33] Green, however, did not back down and continued to speak out against the company across his various social media platforms.[34] After only two days of Green’s vocal online pressure campaign, J&J caved. Stop TB Partnership, a U.N.-hosted TB-fighting organization, announced that, after negotiating with J&J, the company would allow the manufacture of generic bedaquiline in low- and middle-income countries where it was so desperately needed.[35]

When John Green spoke at the U.N. high-level meeting in September, he explained how today, tuberculosis deaths are not the results of a bacterium.[36] When patients of TB, a curable disease, die because human-built socioeconomic systems prevent them from accessing the treatments that would cure them, their deaths are “caused by … human choice.”[37] Green went on to urge the other participants of the meeting to change this reality: “We have chosen the world that we share today and we can choose a better world. We are currently choosing a world where 1.6 million people die of tuberculosis and I believe that with your help together … we will choose a world where no one dies of tuberculosis.”[38]

Green and his fellow activist’s work has been impactful. At the conclusion of the meeting, Member States approved a political declaration renewing their vow to end TB by 2030.[39] The declaration, which they drafted for General Assembly adoption, frequently stresses the importance of guaranteeing access to TB medications.[40] The new resolution mentions the necessity of ensuring access to generic TB treatments three times; the 2018 version only did so once.[41]

J&J is a company worth over 300 billion dollars.[42] And yet, in a matter of days, hardworking activists, a passionate author, and a social-justice-oriented online community were able to bring a megacorporation to its knees. This advocacy blocked the evergreening of a patent, impacted policymaking at the highest intergovernmental levels, and saved thousands of lives. Looking to the future, it is clear that grassroots activism is a key tool in the fight against TB and healthcare injustice.

Rachel Bier is a Staff Editor at CICLR.

[1] Ilaria Barberis, Nicola Luigi Bragazzi, Lucia Galluzzo & Mariano Martini, The History of Tuberculosis: From the First Historical Records to the Isolation of Koch's Bacillus, 58 J. Preventative Med. Hygiene E9, E9 (2017). [2] Report of the High-Level Consultation on Accelerating the Development of the M72/AS01E Tuberculosis Vaccine Candidate, at 1, World Health Organization [WHO] (2019), []. [3] History of World TB Day, Treatment, Centers for Disease Control and Prevention [CDC], []. [4] World Health Organization [WHO], Status Update: Reaching the Targets in the Political Declaration of the United Nations General Assembly High-level Meeting on the Fight Against Tuberculosis, at 2, WHO/UCN/TB/2023.4 (Sept. 2023) [hereinafter Status Update]. [5] Id. [6] Id. [7] Tuberculosis, WHO: Fact Sheets (Apr. 21, 2023) [] [hereinafter Fact Sheets]. [8] G.A. Res. 73/3, at 1 (Oct. 18, 2018). [9] TB is a Pandemic, TB Alliance,,1.6%20million%20in%202021%20alone []. [10] Id. [11] Id. [12] Status Update, supra note 4, at 2. [13] Preparing for the UN High-level Meeting on the Fight Against Tuberculosis, 2023, WHO, []. [14] Id. [15] Vlogbrothers, John Goes … to the UNITED NATIONS?, YouTube (Sept. 27, 2023), [hereinafter John Goes]. [16] John Green, About John Green, []. [17] Jenny Lei Ravelo, 4 Questions for John Green, the 'Tuberculosis Hater', devex (Oct. 5, 2023), []. [18] PIH Urges Further Steps to Ensure TB Drugs Available to All, Partners in Health (July 13, 2023), []. [19] Nerdfighteria Newsletter, []. [20] Treatment of Multidrug-Resistant TB: Bedaquiline Fact Sheet, CDC, [] [hereinafter Bedaquiline Fact Sheet]. [21] Lucy Tu, How Advocates Pushed Big Pharma to Cut Tuberculosis Drug Prices, Sci. Am. (Aug. 12. 2023), []. [22] See Bedaquiline Fact Sheet, supra, note 20. [23] John Green, Why is a Curable Disease Still Allowed to Kill Millions?, Wash. Post: Opinions (May 16, 2023, 6:00 AM), []. [24] Id. [25] Id. [26] Id. [27] Id. [28] Id. [29] Vlogbrothers, Barely Contained Rage: An Open Letter to Johnson & Johnson, YouTube (July 11, 2023), [30] Id. [31] Id.; see also Our Credo, Johnson & Johnson, []. [32] See Vlogbrothers, supra note 29. [33] Johnson & Johnson (@JNJNews), Twitter (July 12, 2023, 12:38 PM), (“It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.”). [34] John Green (@johngreen), Twitter (July 12, 2023, 5:36 PM),; Id. (July 12, 2023, 6:12 PM),; Id. (July 13, 2023, 11:11 AM),; John Green (@literallyjohngreen), TikTok (July 12, 2023), [35] Global Drug Facility Update on Access to Bedaquiline, Stop TB Partnership (July 13, 2023), []. [36] See John Goes, supra note 15. [37] Id. [38] Id. [39] U.N. GAOR, 78th Sess., at 1, U.N. Doc. A/78/L.4 (Sept. 25, 2023). [40] Id.; cf. G.A. Res. 73/3, supra note 8. [41] See U.N. Doc. A/78/L.4., supra note 39, at 11, 13; cf. G.A. Res. 73/3, supra note 8, at 11. [42] Johnson & Johnson, Financial Times, [].


bottom of page